Advanced by Nature
Ingenza is a biotechnology company specialising in the design, development and manufacture of diverse, high-value industrial products and therapeutic-proteins. We exploit synergies between synthetic and evolutionary biology, providing next generation microbial and mammalian manufacturing platforms.
What makes Ingenza unique?
Dynamic teamwork forged from full integration between the in-house molecular biology, fermentation and chemistry teams, boosted by close ties to UK universities, provides the perfect skillsets to expertly guide you through your project. We can support you at any stage of development, from proof of concept to scaled-up manufacture under GMP conditions.
Combining the old and the new
Ingenza’s ethos is all about combining the best tried-and-tested traditional methods, the latest breakthroughs and technologies, and a healthy dose of experience and expertise, to bring refreshing innovation to the development of sustainable and cost-competitive biotechnology.
Ingenza supports COVID-19 response
Ingenza is applying its proprietary “visABLE” biomanufacturing platform in a recombinant bioprocess to accelerate development and testing of a COVID-19 vaccine.
The work is in collaboration with leading UK academic/innovation centres. If successful the biomanufacturing platform will facilitate rapid scale-up and production of vaccine components.
For the latest developments from Ingenza’s COVID-19 response, follow us @IngenzaLtd